参考文献/References:
[1]DiMasi J A,Hansen R W,Grabowski H G.The price of innovation:new estimates of drug development costs[J].J Health Econ,2003,22:151-185.
[2]Kola I,Landis J.Can the pharmaceutical industry reduce attrition rates [J].Nature Rev Drug Discov,2004,3:711-716.
[3]Abou-Gharbia M,Childers W E.Discovery of innovative therapeutics:Today's realities and tomorrow's vision.2.
pharma's challenges and their commitment to innovation[J].J Med Chem,2014,doi:10.1021/jm401564r.
[4]Hornberg J J, Laursen M, Brenden N, et al. Exploratory toxicology as an integrated part of drug discovery[J].Drug Discovery Today, 2014, doi: 10.1016/j.drudis.2013.12.008.
[5]Leeson P D,Springthorpe B.The influence of drug-like concepts on decision-making in medicinal chemistry[J].Nature Rev Drug Discov,2007,6:881.
[6]Wenlock M C,Austin R P,Barton P,et al.A comparison of physiochemical property profiles of development and marketed oral drugs[J].J Med Chem,2003,46:1250.
[7]Perola E.An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs[J].J Med Chem,2010,53:2986-2997.
[8]Shultz M D.The thermodynamic basis for the use of lipophilic efficiency(LipE)in enthalpic optimizations[J].Bioorg Med Chem Lett,2013,23:5992-6000.
[9]Hopkins A L,Keseru G M,Leeson P D,et al.The role of ligand efficiency metrics in drug discovery[J].Nature Rev Drug Discov,2014,13:105-121.
[10]Lipinski C A,Lombardo F,Dominy B W,et al.Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings[J].Drug Del Rev,1997,23:3-25.
[11]Veber D F,Johnson S R,Cheng H Y,et al.Molecular properties that influencethe oral bioavailability of drug candidates[J].J Med Chem,2002,45:2615-2623.
[12]Timothy J R,Simon J F M.The impact of aromatic ring count on compound developability are too many aromatic rings a liability in drug design[J].Drug Discovery Today,2009,14:1011-1020.
[13]Lovering F,Bikker J,Humblet C.Escape from flatland:Increasing saturation as an approach to improving clinical success[J].J Med Chem,2009,52:6752-6756.
[14]Jain N,Yalkowsky S H.Estimation of the aqueous solubility Ⅰ:Appliacationto organic nonelectrolytes[J].J Pharm Sci,2001,90:234-252.
[15]Hughes J D,Blaqq J,Price D A,et al.Physiochemical drug properties associated with in vivo toxicological outcomes[J].Bioorg Med Chem Lett,2008,18:4872-4875.